RYM

RYTHM, Inc. (RYM) - Q1 2026 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended March 31, 2026. RYTHM, Inc. (formerly Agrify Corporation) has repositioned itself as a distributor of hemp-derived THC beverages and licensed brands, including Señorita, RYTHM, and Incredibles. The company exited its legacy cultivation and extraction businesses in late 2024 and early 2025, which are now reported as discontinued operations. The company is classified as a smaller reporting company and an emerging growth company.

Key Financial Metrics

Note: Net income for Q1 2026 is primarily driven by a non-cash income tax benefit of $25.6 million resulting from the release of a valuation allowance.

Material Changes vs. Prior Period

• Revenue Surge: Revenue increased 2,370% year-over-year, driven by the commencement of Licensing Revenue ($10.0 million) from related party agreements with Green Thumb Industries Inc. Non-licensing product revenue also grew 515% to $3.3 million.
• Profitability Shift: The company reported a net income of $19.9 million compared to a net loss of $1.6 million in the prior year. This reversal is almost entirely attributable to the $25.6 million non-cash tax benefit, as the company still reported an operating loss of $4.0 million.
• Debt Structure: Total debt obligations increased significantly to $80.6 million, consisting of $72.0 million in related party convertible notes and $8.0 million in third-party convertible notes. All debt is classified as current.
• Asset Composition: Total assets grew to $127.5 million, largely due to the recognition of $46.0 million in "Related party prepaid license rights" and a new deferred tax asset of $25.6 million.

Guidance, Outlook, and Risks

• Licensing Revenue Model: Effective April 1, 2026, licensing agreements with Green Thumb were amended to replace sales-based royalties with fixed annual fees of $70 million, subject to CPI escalation. This provides more predictable revenue visibility.
• Liquidity and Going Concern: Management states that $33.3 million in cash and anticipated licensing revenue are sufficient to meet obligations for the next 12 months. However, the company notes that if holders of the $80 million in convertible notes elect cash repayment at maturity (Nov 2026/Feb 2027), it could raise substantial doubt about the company's ability to continue as a going concern. Management expects these obligations to be addressed via extension or conversion.
• Related Party Dependence: A single related party customer accounted for 75% of total revenue and 79% of accounts receivable in Q1 2026. Green Thumb also holds significant debt and warrants.
• Regulatory Risk: Potential changes to the definition of hemp under the 2026 Appropriations Act could trigger repurchase rights held by Green Thumb for the intellectual property assets acquired in 2025.
• Legal Contingencies: The company faces ongoing litigation regarding its former cultivation business (Bud & Mary's, Bowdoin Construction, McCutchan), with $1.5 million funded into escrow to settle these claims.

Investor Verification Checklist

• Debt Conversion Terms: Verify the likelihood of the $80 million convertible notes being converted to equity versus repaid in cash, given the company's limited cash reserves relative to the debt principal.
• Related Party Transactions: Scrutinize the sustainability of the $70 million annual fixed licensing fee and the terms of the shared services agreement with Green Thumb, which covers significant operational costs.
• Regulatory Impact: Monitor the status of the 2026 Appropriations Act regarding hemp-derived THC, as its enactment could trigger asset repurchase clauses.
• Non-Cash Income Quality: Assess the quality of earnings by excluding the $25.6 million one-time tax benefit to understand the underlying operational cash burn.
• Legal Escrow: Confirm the status of the $1.5 million litigation escrow and potential exposure beyond this amount.